Clinical Trial Update: A Study of BGM0504 in Poorly Controlled Type 2 Diabetes Patients Only Through Diet and Exercise [Phase 3]

View source ↗

Summary

Phase 3 study evaluating BGM0504 in poorly controlled Type 2 Diabetes Mellitus patients managed with diet and exercise is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• BGM0504

Snippet

Sponsor: BrightGene Bio-Medical Technology Co., Ltd. | Conditions: Type 2 Diabetes Mellitus (T2DM) | Phase 3 | Status: RECRUITING